Cargando…

The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis

BACKGROUND: Multiple studies have reported that cannabis administration in multiple sclerosis patients is associated with decreased symptom severity. This study was conducted to evaluate the prevalence of cannabis abuse in multiple sclerosis cases and to evaluate the effect of cannabis on serum cyto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mustafa, Wessam, Elgendy, Nadia, Salama, Samer, Jawad, Mohamed, Eltoukhy, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884151/ https://www.ncbi.nlm.nih.gov/pubmed/33628507 http://dx.doi.org/10.1155/2021/6611897

Ejemplares similares

Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients
por: Taalab, Yasmeen M., et al.
Publicado: (2019)

Cannabis and Multiple Sclerosis—The Way Forward
por: Rudroff, Thorsten, et al.
Publicado: (2017)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
por: Haddad, Fatma, et al.
Publicado: (2022)

Standardized cannabis in multiple sclerosis: a case report
por: Hornby, Paul, et al.
Publicado: (2010)

Cannabis and cognitive functioning in multiple sclerosis: The role of gender
por: Patel, Viral P, et al.
Publicado: (2017)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials
por: Najafi, Parisa, et al.
Publicado: (2022)

Multiple sclerosis, cannabis, and cognition: A structural MRI study
por: Romero, Kristoffer, et al.
Publicado: (2015)

Cannabis-based product use in a multiple sclerosis cohort
por: Schabas, AJ, et al.
Publicado: (2019)

Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis
por: Melamud, Mark M., et al.
Publicado: (2022)

Pathogenic T cell cytokines in multiple sclerosis
por: Wagner, Catriona A., et al.
Publicado: (2019)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020)

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
por: Rudroff, Thorsten
Publicado: (2019)

Evaluating sex hormones and cytokine profile in Egyptian females with relapsing-remitting multiple sclerosis
por: Talaat, Forayssa M., et al.
Publicado: (2018)

Inflammatory Cytokines and Physical Activity in Multiple Sclerosis
por: Florindo, Margarida
Publicado: (2014)

Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
por: Amedei, Amedeo, et al.
Publicado: (2012)

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
por: Hu, William T., et al.
Publicado: (2019)

Transcranial Doppler for Early Prediction of Cognitive Impairment after Aneurysmal Subarachnoid Hemorrhage and the Associated Clinical Biomarkers
por: Esmael, Ahmed, et al.
Publicado: (2020)

The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients
por: Walawska-Hrycek, Anna, et al.
Publicado: (2021)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
por: Lakhan, Shaheen E, et al.
Publicado: (2009)

Cytokine Control of Inflammation and Repair in the Pathology of Multiple Sclerosis
por: Rodgers, Jane M., et al.
Publicado: (2012)

Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications
por: Palle, Pushpalatha, et al.
Publicado: (2017)

Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2013)

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
por: D’Angelo, Chiara, et al.
Publicado: (2018)

Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [(18)F]-Fluorodeoxyglucose Positron Emission Tomography Study
por: Kindred, John H., et al.
Publicado: (2018)

Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis
por: Cha, Lilian, et al.
Publicado: (2018)

Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary
por: Feinstein, Anthony, et al.
Publicado: (2021)

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2013)

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2014)

Fatigue in Patients with Multiple Sclerosis: Is It Related to Pro- and Anti-Inflammatory Cytokines?
por: Malekzadeh, Arjan, et al.
Publicado: (2015)

Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Khaibullin, Timur, et al.
Publicado: (2017)

Cytokines status in multiple sclerosis patients with comorbid recurrent depressive disorder
por: Markova, E., et al.
Publicado: (2021)

Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis
por: Elgendy, Sherein G., et al.
Publicado: (2021)

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
por: Romme Christensen, Jeppe, et al.
Publicado: (2012)

Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
por: Martynova, Ekaterina, et al.
Publicado: (2020)

Web-based information on the treatment of the mouth in systemic sclerosis
por: Abdouh, Ismail, et al.
Publicado: (2020)

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
por: Oreja-Guevara, Celia, et al.
Publicado: (2012)

Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients
por: Menascu, Shay, et al.
Publicado: (2020)

Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
por: Matsushita, Takuya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2hnpvg758vdu0hu8o58a1j0ajf